ESR1 and neoplasm: CCNB1 expression is elevated in breast cancer tissue, and the expression of this biomarker demonstrates a significant correlation with patient survival time, tumor burden, methylation, infiltration of immune cells, as well as the absence of estrogen receptor expression [37].